Bibliography for Levocarnitine for End Stage Renal Disease
Ahmad S, Robertson T, Golper T, Wolfson M et al. Multicenter trial of l-carnitine in maintenance hemodialysis patients . II. Clinical and biochemical effects. Kidney International 1990; 38:912-918.
Bellinghieri G, Savica V, Mallamace A, DiStefano C, et al. Correlation between increased serum an tissue l-carnitine levels and improved muscle symptoms in hemodialyzed patients. American Journal of Clinical Nutrition 1983; 38:523-531.
Bertoli M, Battistella PA, Vergani L, Naso A, et al. Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy. American Journal of Clinical Nutrition 1981; 34:1496-1500.
Brass EP, Adler S, Sietsema KE, Hiatt WR, et al. Intravenous l-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. American Journal of Kidney Diseases 2001; 37:1018-1028.
Caruso U, Cravotto E, Tisone G, Elli M, et al. Long-term treatment with l-carnitine in uremic patients undergoing chronic hemodialysis: effects on the lipid pattern. Current Therapeutic Research 1983; 33:1098-1104.
Caruso U, Leone L, Cravotto E, Nava D.. Effects of L-carnitine on anemia in aged hemodialysis patients treated with recombitant human erythropoietin: a pilot study.. Dialysis and Transplantation 1998; 27::498-506.
Casciani C, Caruso U, Votto E, Corsi M, et al. Beneficial effects of l-carnitine in post-dialysis syndrome. Current Therapeutic Research 1982; 32:116-127.
Chan MK, Persaud J, Varghese Z, Baillod R, et al. Response patterns to DL-carnitine in patients on maintenance hemodialysis. Nephron 1982; 30:240-243.
Elisaf M, Bairaktari E, Katopodis K, Pappas M, et al. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients. American Journal of Nephrology 1998; 18:416-421.
Fagher B, Cederblad G, Eriksson M, Monti M, et al. L-carnitine and haemodialysis: double blind study on muscle function and metabolism and peripheral nerve function. Scandinavian Journal of Clinical Laboratory Investigation 1985; 45:169-178.
Fagher B, Cederblad G, Monti M, Olsson L et al. Carnitine and left ventricular function in hemodialysis patients. Scandinavian Journal of Clinical Laboratory Investigation 1985; 45:193-198.
Giovenali P, Fenocchip D, Montanari G, Cancellotti C, et al. Selective trophic effect of l-carnitine in type I and II a skeletal muscle fibers.. Kidney International 1994; 46:1616-1619.
Golper TA, Wolfson M, Ahmad S, Hirschberg R, et al. Multicenter trial of l-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.. Kidney International 1990; 38:904-911.
Guarnieri GF, Ranieri F, Togio G, Vasile A, et al. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. American Journal of Clinical Nutrition 1980; 33:1489-1492.
Kletzmayr J, Mayer G, Legenstein E, Heinz-Peer G, et al. Anemia and carnitine supplementation in hemodialyzed patients. Kidney International 1999; 55:S93-S106.
Labonia WD. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. American Journal of Kidney Diseases 1995; 26:757-764.
Lacour B, Chanard J, Haguet M, Basile C, et al. Carnitine improves lipid anomalies in hemodialysis patients. Lancet 1980; :763-764.
Maebashi M, Imamura A, Yoshinaga K, Sato T, et al. Carnitine depletion as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis. Tohoku Journal of Experimental Medicine 1983; 139:33-42.
Matsumura M, Hatakeyama S, Koni I, Mabuchi H, et al. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron 1996; 72:574-578.
Nilsson-Ehle P, Cederblad G, Fagher B, Monti M, et al. Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients: lack of effect of l-carnitine supplementation. Scandinavian Journal of Clinical Laboratory Investigation 1985; 45:179-184.
Rocchi L, Feola I, Calvani M, D'Iddio S, et al. Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography. Drugs Experimental Clinical Research 1986; 12:707-711.
Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, et al. Effects of l-carnitine supplementation on muscular symptoms in hemodialyzed patients. American Journal of Kidney Disease 1998; 32:258-264.
Semeniuk J, Shalansky KF, Taylor N, Jastrzebski J, et al. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients. Clinical Nephrology 2000; 54:470-477.
Siami G, Clinton ME, Mrak R, Griffis J, et al. Evaluation of the effect of intravenous l-carnitine therapy on function, structure, and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis. Nephron 1991; 57:306-313.
Sloan RS, Kastan B, Rice SI, Sallee CW, et al. Quality of life during and between hemodialysis treatments: role of l-carnitine supplementation. American Journal of Kidney Diseases 1998; 32:265-272.
Spagnoli LG, Palmieri G, Mauriello A, Vacha G, et al. Morphometric evidence of the trophic effect of l-carnitine on human skeletal muscle. Nephron 1990; 55:16-23.
Srivastava DK, Kumar S, Misra AP. Reversal of haemodialysis induced hypertriacylglycerolemia by l-carnitine. Indian Journal of Clinical Biochemistry 1992; 7:19-21.
Suzuki Y, Narita M, Yamazaki N.. Effects of l-carnitine on arrhythmias during hemodialysis. Japan Heart Journal 1982; 23:349-359.
Thomas S, Fischer FP, Mettang T, Pauli-Magnus C, et al. Effects of l-carnitine on leukocyte function and viability in hemodialysis patients: a double-blind randomized trial. American Journal of Kidney Disease 1999; 34:678-687.
Trovato G, Ginardi V, Di Marco V, Dell'aira A, et al. Long-term L-carnitine treatment of chronic anaemia of patients with end-stage renal failure. Current Therapeutic Research 1982; 31:1042-1049.
Vacha GM, Giorcelli G, DiIddio S, Valentini G, et al. L-carnitine addition to dialysis fluid: a therapeutic alternative to hemodialysis patients.. Nephron 1989; 51:237-242.
Vacha GM, Giorcelli G, Siliprandi N, Corsi M.. Favorable effects of l-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol. American Journal of Clinical Nutrition 1983; 38:532-540.
Van Es A, Henny FC, Kooistra MP, Lobatto S, et al. Amelioration of cardiac function by l-carnitine administration in patients on haemodialysis. Contributions Nephrology 1992; 98:28-35.
Wanner C, Forstner-Wanner S, Schaeffer G, Schollmeyer P, et al. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. American Journal of Nephrology 1986; 6:206-211.
Weschler A, Aviram M, Levin M, Better O, et al. High dose of l-carnitine increases platelet aggregation and plasma trigylceride levels in uremic patients in hemodialysis. Nephron 1984; 38:120-124.
Yderstraede KB, Pedersen FB, Dragsholt C, Trostmann A et al. The effect of l-carnitine on lipid metabolism in patients on chronic haemodialysis. Nephrology Dialysis Transplantation 1987; 1:238-241.
|